This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
mannich bases | 842 |
antiviral activity | 318 |
cell lines | 281 |
mg ml | 251 |
inhibitory activity | 226 |
reference drug | 215 |
antibacterial activity | 208 |
mg kg | 193 |
antifungal activity | 183 |
ic values | 168 |
biological activity | 155 |
mannich base | 152 |
active site | 147 |
virtual screening | 138 |
cell line | 137 |
amino acid | 136 |
influenza virus | 135 |
natural products | 133 |
cancer cell | 131 |
coumarin derivatives | 125 |
molecular docking | 115 |
clinical trials | 114 |
bioactive compounds | 108 |
biological activities | 108 |
cancer cells | 103 |
broccoli sprouts | 103 |
antimicrobial activity | 102 |
biological evaluation | 99 |
amino acids | 98 |
active compounds | 94 |
antioxidant activity | 91 |
secondary metabolites | 89 |
bases derived | 89 |
side chain | 89 |
drug discovery | 82 |
crystal structure | 82 |
docking studies | 82 |
phenolic mannich | 79 |
mannich reaction | 78 |
metabolic pathway | 78 |
room temperature | 78 |
respiratory syndrome | 78 |
synthesized compounds | 77 |
mic values | 76 |
breast cancer | 75 |
binding site | 73 |
protease inhibitors | 72 |
tested compounds | 72 |
compounds showed | 71 |
amino group | 71 |
binding affinity | 70 |
doc id | 70 |
psoralea corylifolia | 70 |
cord uid | 70 |
activity relationship | 69 |
acute respiratory | 68 |
derivatives synthesis | 65 |
compound showed | 64 |
severe acute | 64 |
plasmodium falciparum | 64 |
vero cells | 64 |
viral replication | 64 |
column chromatography | 63 |
small molecule | 62 |
kcal mol | 62 |
test compounds | 61 |
phenyl ring | 61 |
hydrogen bond | 61 |
bglu activity | 61 |
cell culture | 61 |
ec values | 60 |
hepg cells | 60 |
side effects | 60 |
medicinal chemistry | 60 |
molecular modeling | 60 |
activity relationships | 60 |
antiviral drugs | 59 |
drug design | 59 |
silica gel | 58 |
free energy | 57 |
less active | 57 |
reaction mixture | 56 |
general procedure | 56 |
pathway classes | 56 |
wide range | 56 |
small molecules | 55 |
cell cultures | 55 |
aromatic ring | 55 |
amine reagents | 54 |
cytotoxic activity | 54 |
antiviral agents | 54 |
hydroxyl group | 54 |
related compounds | 54 |
carboxylic acid | 53 |
selected compounds | 53 |
anticancer activity | 53 |
antiviral activities | 52 |
ebola virus | 52 |
mouse model | 51 |
main protease | 51 |
hydrogen bonding | 51 |
new compounds | 50 |
broad spectrum | 50 |
ic value | 50 |
herpes simplex | 50 |
virus replication | 50 |
endophytic fungus | 50 |
inflammatory activity | 49 |
simplex virus | 49 |
biologically active | 49 |
united states | 48 |
animal models | 47 |
potent inhibitors | 47 |
binding pocket | 47 |
oxidative stress | 47 |
infected cells | 47 |
cell viability | 46 |
give compound | 46 |
ns pro | 46 |
methionine aminopeptidase | 46 |
inhibitory effect | 46 |
antitumor activity | 45 |
qsar model | 45 |
leucine aminopeptidase | 45 |
growth inhibition | 45 |
cell death | 45 |
antiproliferative activity | 45 |
phenolic compounds | 44 |
nmr spectra | 44 |
compounds exhibited | 44 |
anticonvulsant activity | 44 |
vitro activity | 44 |
cell cycle | 44 |
performed using | 43 |
cl pro | 43 |
anticancer agents | 43 |
isatis tinctoria | 43 |
hydrogen bonds | 43 |
less potent | 43 |
positive control | 42 |
reverse transcriptase | 42 |
medicinal plants | 42 |
molecular dynamics | 42 |
oral administration | 42 |
flash chromatography | 42 |
ketonic mannich | 41 |
selectivity index | 41 |
schiff bases | 41 |
new class | 41 |
phase ii | 40 |
drug resistance | 40 |
like protease | 40 |
inhibitory effects | 40 |
hela cells | 40 |
antimicrobial activities | 40 |
also showed | 40 |
commercially available | 39 |
different concentrations | 39 |
syndrome coronavirus | 39 |
reverse phase | 39 |
cell proliferation | 39 |
antimycobacterial activity | 39 |
rna polymerase | 38 |
fl uorouracil | 38 |
amine reagent | 38 |
results showed | 38 |
two compounds | 38 |
yellow solid | 38 |
virus type | 38 |
large number | 38 |
potent anti | 38 |
drug development | 37 |
resistant strains | 37 |
drug administration | 37 |
vitro anti | 37 |
widely used | 37 |
van der | 37 |
binding mode | 37 |
aliphatic amines | 37 |
organic compounds | 36 |
active compound | 36 |
bacterial strains | 36 |
trypanosomal activity | 36 |
standard drug | 36 |
antiviral compounds | 36 |
prepared compounds | 36 |
nervous system | 36 |
phase flash | 36 |
endophytic fungi | 36 |
binding free | 36 |
double mannich | 36 |
force field | 36 |
reference compounds | 35 |
escherichia coli | 35 |
secondary aliphatic | 35 |
higher activity | 35 |
staphylococcus aureus | 35 |
cov cl | 35 |
inhibitory activities | 35 |
antibacterial agents | 35 |
pro inhibitors | 34 |
cell growth | 34 |
enzyme activity | 34 |
syn aggregation | 34 |
side chains | 34 |
coumarin nucleus | 34 |
ethyl acetate | 34 |
human immunodeficiency | 34 |
binding energy | 34 |
positive bacteria | 34 |
inhibitory potency | 34 |
transition state | 34 |
normal cells | 33 |
phase i | 33 |
inhibition activity | 33 |
animal model | 33 |
tissue culture | 33 |
see scheme | 33 |
essential oils | 33 |
negative bacteria | 33 |
vaccinia virus | 33 |
calculated using | 33 |
virus infection | 33 |
also tested | 32 |
studied compounds | 32 |
acid derivatives | 32 |
mass spectrometry | 32 |
methyl group | 32 |
newly synthesized | 32 |
receptor binding | 32 |
zoster virus | 32 |
potent inhibitor | 32 |
molecular weight | 32 |
novel compounds | 32 |
lead compound | 31 |
dependent manner | 31 |
central nervous | 31 |
type i | 31 |
first time | 31 |
mtt assay | 31 |
well plates | 31 |
see table | 31 |
previous studies | 31 |
marine natural | 31 |
compounds may | 31 |
antiviral effect | 31 |
pseudomonas aeruginosa | 30 |
drug candidates | 30 |
antiviral effects | 30 |
immunodeficiency virus | 30 |
results indicated | 30 |
dipole moment | 30 |
acetic acid | 30 |
throughput screening | 30 |
oral bioavailability | 30 |
bacterial bglu | 30 |
medicinal plant | 30 |
based virtual | 30 |
previously described | 30 |
antioxidant properties | 30 |
results suggest | 30 |
inhibitory concentration | 30 |
metal ions | 30 |
low toxicity | 29 |
new derivatives | 29 |
virus growth | 29 |
studies showed | 29 |
pathogenic fungi | 29 |
reduction assay | 29 |
moderate activity | 29 |
cell membrane | 29 |
influenza viruses | 29 |
growth factor | 29 |
hydrophobic interactions | 29 |
acid residues | 29 |
hiv activity | 29 |
chemical descriptors | 29 |
life cycle | 29 |
plant extracts | 28 |
activity compared | 28 |
cytopathic effect | 28 |
botrytis cinerea | 28 |
showed good | 28 |
mycobacterium tuberculosis | 28 |
infected mice | 28 |
pharmacokinetic properties | 28 |
high affinity | 28 |
der waals | 28 |
proliferative activity | 28 |
good activity | 28 |
host plant | 28 |
highly active | 28 |
clinical studies | 28 |
antimicrobial agents | 28 |
plaque reduction | 28 |
syn oligomers | 27 |
betulinic acid | 27 |
values ranging | 27 |
trypanosoma brucei | 27 |
reduction assays | 27 |
agents synthesis | 27 |
clinical trial | 27 |
novel coronavirus | 27 |
important role | 27 |
determined using | 27 |
novel series | 27 |
fusarium oxysporum | 27 |
radical scavenging | 27 |
antiviral drug | 27 |
hydroxyl groups | 27 |
docking study | 27 |
tumor cell | 27 |
activity towards | 27 |
viral rna | 27 |
antimalarial activity | 27 |
moderately active | 27 |
potent compounds | 27 |
pdb id | 27 |
therapeutic agents | 27 |
naturally occurring | 27 |
virus yield | 27 |
quantitative structure | 26 |
potential anti | 26 |
triazole derivatives | 26 |
scavenging activity | 26 |
respiratory syncytial | 26 |
nitrogen atom | 26 |
human cancer | 26 |
fl uoro | 26 |
potent activity | 26 |
lipid peroxidation | 26 |
dependent rna | 26 |
indole ring | 26 |
dengue virus | 26 |
inhibition assay | 26 |
showed significant | 26 |
fl uorinated | 26 |
nucleic acid | 25 |
virus activity | 25 |
substitution pattern | 25 |
human health | 25 |
public health | 25 |
endothelial cells | 25 |
cpe inhibition | 25 |
fever virus | 25 |
triazole ring | 25 |
broccoli sprout | 25 |
inflammatory drugs | 25 |
oxygen atom | 25 |
infectious diseases | 25 |
closely related | 25 |
sars coronavirus | 25 |
derivatives showed | 25 |
natural compounds | 25 |
enzyme inhibition | 24 |
human lung | 24 |
viral dna | 24 |
ionic liquids | 24 |
biological properties | 24 |
cytokine storm | 24 |
type diabetes | 24 |
syncytial virus | 24 |
results obtained | 24 |
molecular target | 24 |
highly selective | 24 |
aqueous solution | 24 |
chemical structures | 24 |
chalcone analogues | 24 |
viral infection | 24 |
spectrum antiviral | 24 |
surface area | 24 |
ring system | 24 |
cov clpro | 24 |
fatty acids | 24 |
chloroquine resistance | 24 |
topoisomerase i | 24 |
reference drugs | 24 |
pathway class | 24 |
new drugs | 24 |
based compounds | 24 |
metal ion | 23 |
fluorescent probe | 23 |
glucuronidase activity | 23 |
chromatography using | 23 |
bglu inhibitors | 23 |
gene expression | 23 |
partition coefficient | 23 |
candida albicans | 23 |
md simulation | 23 |
evaluated using | 23 |
chemical structure | 23 |
prostate cancer | 23 |
isolated compounds | 23 |
rna viruses | 23 |
rhizoctonia solani | 23 |
enveloped viruses | 23 |
high activity | 23 |
streptomyces sp | 23 |
kg day | 23 |
data determined | 23 |
glucuronidase inhibitors | 23 |
vivo studies | 23 |
high selectivity | 23 |
antiviral properties | 23 |
model obtained | 23 |
spike protein | 22 |
vitro evaluation | 22 |
table iv | 22 |
human breast | 22 |
chemical modification | 22 |
data bank | 22 |
cl protease | 22 |
least one | 22 |
plant species | 22 |
hexamethylene amiloride | 22 |
monoclonal antibody | 22 |
toxic effects | 22 |
fi rst | 22 |
adverse effects | 22 |
plant growth | 22 |
cell wall | 22 |
reactive oxygen | 22 |
three compounds | 22 |
immune response | 22 |
antibacterial activities | 22 |
experimental data | 22 |
tsh fraction | 22 |
lead compounds | 22 |
selective inhibitors | 22 |
also used | 22 |
recent years | 22 |
authors declare | 22 |
less toxic | 22 |
human coronavirus | 22 |
aromatic rings | 22 |
supplementary materials | 22 |
previously reported | 22 |
showed high | 22 |
worth noting | 22 |
ng ml | 22 |
activity evaluation | 22 |
electrostatic potential | 21 |
varicella zoster | 21 |
obtained using | 21 |
highly significant | 21 |
host cell | 21 |
syn fibrils | 21 |
compounding errors | 21 |
ion channel | 21 |
inhibition zones | 21 |
cytotoxic effects | 21 |
converting enzyme | 21 |
highly effective | 21 |
hepatocellular carcinoma | 21 |
mdck cells | 21 |
states food | 21 |
analgesic activity | 21 |
signaling pathway | 21 |
muscodor albus | 21 |
significant reduction | 21 |
structurally related | 21 |
fold less | 21 |
substituted phenyl | 21 |
carboxylic acids | 21 |
viral infections | 21 |
nitro group | 21 |
sar studies | 21 |
aminophosphonic acids | 21 |
selectivity towards | 21 |
protein data | 21 |
carbon atoms | 21 |
pechmann condensation | 20 |
approved drugs | 20 |
molecular mechanics | 20 |
ch cl | 20 |
showed moderate | 20 |
mes test | 20 |
coumarin scaffold | 20 |
may also | 20 |
middle east | 20 |
crystal structures | 20 |
fluorescent probes | 20 |
protein kinase | 20 |
wide variety | 20 |
compounding pharmacies | 20 |
free conditions | 20 |
reference compound | 20 |
gel column | 20 |
low micromolar | 20 |
compounds containing | 20 |
promising compounds | 20 |
another study | 20 |
world health | 20 |
fl uorine | 20 |
protein synthesis | 20 |
cell types | 20 |
metabolic pathways | 20 |
title compound | 20 |
aminomethyl function | 20 |
several studies | 20 |
present study | 20 |
culture medium | 20 |
defense compounds | 20 |
halistanol sulfate | 20 |
prenylated coumarins | 20 |
activity synthesis | 20 |
marine sponge | 20 |
ns protease | 20 |
potent compound | 20 |
hairy root | 20 |
peer review | 20 |
activity comparable | 20 |
structural features | 20 |
site residues | 20 |
rheumatoid arthritis | 19 |
liquid chromatography | 19 |
structural modification | 19 |
endophytic actinomycetes | 19 |
two different | 19 |
compound also | 19 |
hydrogen atoms | 19 |
ic mm | 19 |
enpp inhibitors | 19 |
inhibitors synthesis | 19 |
potential antiviral | 19 |
compound exhibited | 19 |
also found | 19 |
health organization | 19 |
carbonyl group | 19 |
statistically significant | 19 |
cells infected | 19 |
para position | 19 |
test compound | 19 |
research team | 19 |
new anti | 19 |
camphoric acid | 19 |
starting point | 19 |
recent advances | 19 |
commonly used | 19 |
molecule inhibitors | 19 |
also exhibited | 19 |
novel mannich | 19 |
target proteins | 19 |
apoptotic cells | 19 |
ec value | 19 |
diffusion method | 19 |
effective concentration | 19 |
compounds isolated | 19 |
imaging probes | 19 |
epithelial cells | 19 |
nucleoside phosphonates | 19 |
coli bglu | 19 |
synthesized using | 19 |
oxygen species | 19 |
pyrrole ring | 19 |
ki values | 19 |
nmr data | 19 |
yield reduction | 18 |
synuclein aggregation | 18 |
antifungal agents | 18 |
candida activity | 18 |
series i | 18 |
amine moiety | 18 |
several compounds | 18 |
chromone derivatives | 18 |
sleeping sickness | 18 |
interactive compounds | 18 |
outsourcing facilities | 18 |
based design | 18 |
receptor antagonists | 18 |
hiv infection | 18 |
receptor antagonist | 18 |
results revealed | 18 |
east respiratory | 18 |
rosette leaves | 18 |
medium containing | 18 |
experimental conditions | 18 |
previous study | 18 |
monoclonal antibodies | 18 |
cell type | 18 |
low cytotoxicity | 18 |
chemical space | 18 |
dihydrofolate reductase | 18 |
micromolar range | 18 |
free radicals | 18 |
coumarin ring | 18 |
nanomolar range | 18 |
knoevenagel condensation | 18 |
helicobacter pylori | 18 |
drug repurposing | 18 |
potent antiviral | 18 |
hydroxyquinoline derivatives | 18 |
microwave irradiation | 18 |
also investigated | 18 |
antiviral research | 18 |
cytotoxic agents | 18 |
syn aggregates | 18 |
hcv rna | 18 |
double bond | 18 |
independent experiments | 18 |
target compounds | 18 |
functional foods | 18 |
nmr spectrum | 18 |
per well | 18 |
novel inhibitors | 18 |
plant pathogens | 18 |
pharmacological activities | 18 |
mm tris | 18 |
alkyl chain | 18 |
water solubility | 18 |
mice treated | 18 |
phytopathogenic fungi | 18 |
recent studies | 18 |
ferulic acid | 18 |
pharmacological properties | 18 |
catalytic site | 17 |
also known | 17 |
broccoli seedlings | 17 |
minor groove | 17 |
rna synthesis | 17 |
immune stimuli | 17 |
antifungal activities | 17 |
teicoplanin aglycone | 17 |
african trypanosomiasis | 17 |
acyclic nucleoside | 17 |
paw edema | 17 |
significantly reduced | 17 |
human embryonic | 17 |
body weight | 17 |
candidates derived | 17 |
ch ch | 17 |
antiviral efficacy | 17 |
layer chromatography | 17 |
yellow fever | 17 |
aspergillus niger | 17 |
water molecules | 17 |
using various | 17 |
kinase inhibitors | 17 |
fatty acid | 17 |
adrenergic receptor | 17 |
viral proteins | 17 |
natural product | 17 |
therapeutic potential | 17 |
traditional chinese | 17 |
feline infectious | 17 |
energy minimization | 17 |
salicylic acid | 17 |
new series | 17 |
hiv agents | 17 |
chemical compounds | 17 |
based assays | 17 |
inhibition zone | 17 |
antimycobacterial agents | 17 |
cytotoxic concentration | 17 |
results indicate | 17 |
compound may | 17 |
nitric oxide | 17 |
vivo activity | 17 |
active derivatives | 17 |
fungal cell | 17 |
also observed | 17 |
aromatic aldehydes | 17 |
oh group | 17 |
infectious peritonitis | 17 |
exhibited significant | 17 |
lung cancer | 17 |
different types | 17 |
showed activity | 17 |
rna replication | 17 |
pyrimidine derivatives | 17 |
blood pressure | 17 |
fungal pathogens | 17 |
supporting information | 17 |
compounding pharmacy | 17 |
one derivatives | 17 |
health care | 17 |
protease inhibitor | 17 |
root cultures | 17 |
medicinal compounds | 17 |
scoring functions | 17 |
tumour cell | 17 |
anticancer activities | 17 |
sulfonic acid | 16 |
anticoagulant activity | 16 |
thymidine kinase | 16 |
biological material | 16 |
high throughput | 16 |
molecular structure | 16 |
halogen atom | 16 |
broad singlet | 16 |
carcinoma cell | 16 |
per day | 16 |
bismuth compounds | 16 |
human airway | 16 |
highest activity | 16 |
described previously | 16 |
inflammatory activities | 16 |
synthetic methods | 16 |
series ii | 16 |
fungal strains | 16 |
essential oil | 16 |
brain barrier | 16 |
drug fluconazole | 16 |
using molecular | 16 |
carboxamide derivatives | 16 |
polar volume | 16 |
sar study | 16 |
chemokine receptor | 16 |
potential inhibitors | 16 |
chromone core | 16 |
mean square | 16 |
score values | 16 |
protective effects | 16 |
minimum energy | 16 |
hemozoin formation | 16 |
functional groups | 16 |
colon cancer | 16 |
serial dilutions | 16 |
substituted compounds | 16 |
virus infections | 16 |
antioxidant activities | 16 |
ccr cxcr | 16 |
inflammatory cytokines | 16 |
also shown | 16 |
ascorbic acid | 16 |
sweet gel | 16 |
qsar models | 16 |
volatile organic | 16 |
dna viruses | 16 |
ray diffraction | 16 |
enzyme assay | 16 |
tumor growth | 16 |
virus diseases | 16 |
supplementary material | 16 |
derivatives containing | 16 |
study showed | 16 |
hiv replication | 15 |
glucuronic acid | 15 |
virus titers | 15 |
compounds tested | 15 |
treated animals | 15 |
six compounds | 15 |
phenolic hydroxyl | 15 |
human body | 15 |
different mechanisms | 15 |
spectral data | 15 |
target protein | 15 |
glycopeptide antibiotics | 15 |
cells ml | 15 |
indigo precursors | 15 |
dpph radical | 15 |
square deviation | 15 |
potent inhibition | 15 |
vitro antiviral | 15 |
carbonic anhydrase | 15 |
first step | 15 |
two new | 15 |
nucleoside analog | 15 |
pharmacological activity | 15 |
methoxy group | 15 |
widely distributed | 15 |
compound concentration | 15 |
good antibacterial | 15 |
coronavirus disease | 15 |
antitumour activity | 15 |
biofilm formation | 15 |
host plants | 15 |
western blot | 15 |
also evaluated | 15 |
web server | 15 |
antimalarial drug | 15 |
biological functions | 15 |
combination therapy | 15 |
weight loss | 15 |
antiinflammatory activity | 15 |
hydrazine hydrate | 15 |
host cells | 15 |
studies synthesis | 15 |
vesicular stomatitis | 15 |
nitrogen atoms | 15 |
arbuscular mycorrhizal | 15 |
starting material | 15 |
leaf spot | 15 |
compounds using | 15 |
root mean | 15 |
novel anti | 15 |
virology branch | 15 |
last decade | 15 |
synthetic derivatives | 15 |
test set | 15 |
research groups | 15 |
human cells | 15 |
brassica oleracea | 15 |
using mtt | 15 |
primary human | 15 |
compounds bearing | 15 |
virus entry | 15 |
reduced pressure | 15 |
isatin derivatives | 15 |
potential anticancer | 15 |
cells using | 14 |
discovery studio | 14 |
systematic review | 14 |
nmr spectroscopy | 14 |
lewy bodies | 14 |
present work | 14 |
broad range | 14 |
autodock vina | 14 |
living cells | 14 |
prominent activity | 14 |
several mannich | 14 |
affinity energy | 14 |
molecular design | 14 |
showed higher | 14 |
nucleoside analogues | 14 |
brucei rhodesiense | 14 |
new antibiotics | 14 |
dna polymerase | 14 |
chlorine atom | 14 |
increasing concentrations | 14 |
highest concentration | 14 |
chloroquine transport | 14 |
scoring function | 14 |
jurkat cells | 14 |
chemical defense | 14 |
marine organisms | 14 |
substituted coumarins | 14 |
normal cell | 14 |
containing compounds | 14 |
mm nacl | 14 |
cov infection | 14 |
compounds displayed | 14 |
diabetes mellitus | 14 |
novel compound | 14 |
assisted synthesis | 14 |
san diego | 14 |
interaction energy | 14 |
mammalian cells | 14 |
bvdv rdrp | 14 |
target products | 14 |
viability assay | 14 |
organic chemistry | 14 |
mycelial growth | 14 |
bacillus subtilis | 14 |
studies revealed | 14 |
leukemia cells | 14 |
spectrum showed | 14 |
plant pathogenic | 14 |
triazene derivatives | 14 |
mentioned compounds | 14 |
anhydrous na | 14 |
whereas compound | 14 |
negatively charged | 14 |
fl uorination | 14 |
neutral red | 14 |
new drug | 14 |
stomatitis virus | 14 |
method using | 14 |
another approach | 14 |
parent compound | 14 |
mm respectively | 14 |
ros generation | 14 |
chemical entities | 14 |
high levels | 14 |
relationship studies | 14 |
cytotoxicity towards | 14 |
cellular proteins | 14 |
clinical development | 14 |
physicochemical properties | 14 |
inhibitory potential | 14 |
bglu inhibition | 14 |
conformational analysis | 14 |
md simulations | 14 |
cytostatic activity | 14 |
therapeutic efficacy | 14 |
treated cells | 14 |
workers proposed | 14 |
bond interactions | 14 |
docking simulations | 14 |
coumarin complexes | 14 |
enzyme active | 14 |
conformational changes | 14 |
worth mentioning | 14 |
emodin derivatives | 14 |
ii clinical | 14 |
lung adenocarcinoma | 14 |
promising compound | 14 |
two candidates | 14 |
antitubercular activity | 14 |
chemotherapeutic agents | 14 |
phenolic acids | 14 |
metal complexes | 13 |
chemical composition | 13 |
days post | 13 |
inflammatory agents | 13 |
pivot molecule | 13 |
promising anti | 13 |
small number | 13 |
docking analysis | 13 |
human intestinal | 13 |
group displayed | 13 |
mass spectra | 13 |
srb assay | 13 |
hydrazone derivatives | 13 |
future science | 13 |
rich compound | 13 |
new coumarin | 13 |
three independent | 13 |
periodontal disease | 13 |
best compounds | 13 |
also reported | 13 |
chinese medicine | 13 |
new mannich | 13 |
significant linear | 13 |
carboxyl group | 13 |
better activity | 13 |
aggregation inhibitors | 13 |
treated mice | 13 |
pc cells | 13 |
base derived | 13 |
antiviral therapy | 13 |
extracts showed | 13 |
years ago | 13 |
orally bioavailable | 13 |
added dropwise | 13 |
indole derivatives | 13 |
drug indomethacin | 13 |
higher affinity | 13 |
final concentration | 13 |
silico studies | 13 |
alkyl chains | 13 |
estrogen receptor | 13 |
compounded medications | 13 |
antioxidant capacity | 13 |
competitive inhibitor | 13 |
structure activity | 13 |
minimum inhibitory | 13 |
tumor cells | 13 |
towards human | 13 |
showed prominent | 13 |
dna synthesis | 13 |
standard deviation | 13 |
current study | 13 |
rat paw | 13 |
immune system | 13 |
hybrid molecules | 13 |
drug diclofenac | 13 |
acid moiety | 13 |
significant increase | 13 |
ionic liquid | 13 |
vero cell | 13 |
query compound | 13 |
two steps | 13 |
androgen receptor | 13 |
withdrawing group | 13 |
free radical | 13 |
three new | 13 |
showed strong | 13 |
ms ms | 13 |
benzene ring | 13 |
lmqc structures | 13 |
may contribute | 13 |
anticonvulsant agents | 13 |
organic synthesis | 13 |
corylifolia extract | 13 |
promising results | 13 |
cytotoxic properties | 13 |
linear regression | 13 |
may help | 13 |
strong inhibitory | 13 |
hydrogen atom | 13 |
ray crystallographic | 13 |
much lower | 13 |
binding affinities | 13 |
chemical constituents | 13 |
methyl ester | 13 |
significant inhibition | 13 |
drug ciprofloxacin | 13 |
dna replication | 13 |
well known | 13 |
molar refractivity | 13 |
human rhinovirus | 13 |
science group | 13 |
resistant strain | 13 |
acid group | 13 |
oxadiazole derivatives | 13 |
vitro studies | 13 |
attractive target | 13 |
cellular uptake | 13 |
respiratory tract | 13 |
workers synthesized | 13 |
homology modeling | 13 |
chemical properties | 13 |
plaque assay | 13 |
piperazine ring | 13 |
cauline leaves | 13 |
human cervical | 13 |
aminomethyl group | 13 |
human liver | 13 |
superoxide dismutase | 13 |
tyrosine kinase | 13 |
previous work | 12 |
docking poses | 12 |
cells treated | 12 |
compounds will | 12 |
results suggested | 12 |
based fluorescent | 12 |
weak activity | 12 |
much higher | 12 |
mobile phase | 12 |
less cytotoxic | 12 |
bioactivity scores | 12 |
aspergillus flavus | 12 |
functional group | 12 |
cancer activity | 12 |
cancer drug | 12 |
high concentrations | 12 |
induced seizures | 12 |
last years | 12 |
obtained results | 12 |
disease caused | 12 |
homo sapiens | 12 |
direct fl | 12 |
amino groups | 12 |
showed ic | 12 |
variously substituted | 12 |
good agreement | 12 |
phosphate derivatives | 12 |
million people | 12 |
even though | 12 |
structural basis | 12 |
physiological ph | 12 |
ray crystallography | 12 |
valproic acid | 12 |
fold higher | 12 |
based assay | 12 |
energy conformations | 12 |
mitochondrial membrane | 12 |
liver microsomes | 12 |
activities synthesis | 12 |
common cold | 12 |
mice infected | 12 |
melting points | 12 |
chemical shifts | 12 |
disease control | 12 |
derivatives exhibited | 12 |
cell division | 12 |
available drugs | 12 |
patient harm | 12 |
substituted derivatives | 12 |
human cytomegalovirus | 12 |
marine sponges | 12 |
anticancer drug | 12 |
structurally diverse | 12 |
concentration range | 12 |
receptor ligands | 12 |
fold increase | 12 |
binding sites | 12 |
chemical stability | 12 |
whole plant | 12 |
acute toxicity | 12 |
airway epithelial | 12 |
dry dmf | 12 |
derivatives bearing | 12 |
zinc ions | 12 |
cytotoxic activities | 12 |
showed low | 12 |
colorimetric assay | 12 |
factor receptor | 12 |
bioactive molecules | 12 |
coumarin derivative | 12 |
inflammatory mediators | 12 |
inhibitory concentrations | 12 |
reversed chloroquines | 12 |
antifungal compounds | 12 |
multidrug resistant | 12 |
avian influenza | 12 |
monoamine oxidase | 12 |
showed potent | 12 |
plaque formation | 12 |
simulated annealing | 12 |
crystallographic structure | 12 |
medical research | 12 |
one candidate | 12 |
diphenyltetrazolium bromide | 12 |
antimicrobial compounds | 12 |
i values | 12 |
elemental analysis | 12 |
cs co | 12 |
candidate compounds | 12 |
chronic diseases | 12 |
cytotoxicity studies | 12 |
herpes zoster | 12 |
disc diffusion | 12 |
low concentrations | 12 |
antitumor agents | 12 |
viral plaque | 12 |
ki mice | 12 |
many alkaloids | 12 |
training set | 12 |
hybrid compounds | 12 |
secondary amine | 12 |
aspergillus spp | 12 |
viral entry | 12 |
cell entry | 12 |
produced less | 12 |
showed excellent | 12 |
even better | 12 |
orally active | 12 |
inflammatory response | 12 |
electron withdrawing | 12 |
structural similarity | 12 |
sequence alignment | 12 |
new antiviral | 12 |
phase iii | 12 |
much less | 12 |
feline coronavirus | 12 |
novel class | 12 |
aromatic amines | 12 |
significant activity | 12 |
cytotoxic effect | 12 |
crop loss | 12 |
fold superior | 11 |
neutralizing antibodies | 11 |
dna binding | 11 |
potential drugs | 11 |
therapeutic target | 11 |
one study | 11 |
hydroxy group | 11 |
microwave heating | 11 |
ring systems | 11 |
uorinated diazines | 11 |
food products | 11 |
containing diazines | 11 |
secondary amines | 11 |
table i | 11 |
consensus scoring | 11 |
quantum chemical | 11 |
schiff base | 11 |
containing two | 11 |
virus strains | 11 |
novel derivatives | 11 |
phenyl moiety | 11 |
showed selectivity | 11 |
potent inhibitory | 11 |
magnetic resonance | 11 |
protein backbone | 11 |
cycle arrest | 11 |
benzoxazine ring | 11 |
assay using | 11 |
drug ampicillin | 11 |
high cytotoxicity | 11 |
bioactive constituents | 11 |
highest binding | 11 |
pharmacological evaluation | 11 |
therapeutic use | 11 |
coronavirus infection | 11 |
specific inhibitors | 11 |
nh group | 11 |
klebsiella pneumoniae | 11 |
vitro assays | 11 |
glucuronidase inhibitory | 11 |
oxygen atoms | 11 |
docking results | 11 |
carbonic anhydrases | 11 |
cells well | 11 |
preformed fibrils | 11 |
rhesus macaques | 11 |
strong activity | 11 |
distance geometry | 11 |
active sites | 11 |
pestalotiopsis microspora | 11 |
therapeutic applications | 11 |
coworkers prepared | 11 |
anticancer drugs | 11 |
step hydrolysis | 11 |
receptor affinity | 11 |
drug delivery | 11 |
compounds based | 11 |
based drug | 11 |
north america | 11 |
good yields | 11 |
ring nitrogen | 11 |
rat liver | 11 |
mers ma | 11 |
three mannich | 11 |
benzimidazole derivatives | 11 |
causal agent | 11 |
synthetic analogues | 11 |
showed weak | 11 |
ion channels | 11 |
hydroxy groups | 11 |
triazole moiety | 11 |
antibiotic resistance | 11 |
internal standard | 11 |
innate immune | 11 |
enzyme inhibitors | 11 |
potential therapeutic | 11 |
synthetic strategy | 11 |
well tolerated | 11 |
gel chromatography | 11 |
binding modes | 11 |
biological control | 11 |
trifl uoromethyl | 11 |
gel coatings | 11 |
monkey kidney | 11 |
antiviral potency | 11 |
excellent activity | 11 |
methylene group | 11 |
carcinoma cells | 11 |
kj mol | 11 |
human tumor | 11 |
quinolizidine alkaloids | 11 |
exhibited good | 11 |
diabetic patients | 11 |
amyloid proteins | 11 |
compounds inhibited | 11 |
stronger inhibitors | 11 |
antifungal agent | 11 |
compound displayed | 11 |
organic layer | 11 |
target prediction | 11 |
leaf extracts | 11 |
cardiovascular diseases | 11 |
protecting group | 11 |
significantly different | 11 |
fluorine atom | 11 |
phenolic group | 11 |
base derivatives | 11 |
new potential | 11 |
micromolar concentrations | 11 |
atp synthase | 11 |
human plasma | 11 |
type ii | 11 |
acid functionalized | 11 |
viral diseases | 11 |
sea urchin | 11 |
pyrrole mannich | 11 |
novel synthesis | 11 |
using srb | 11 |
chem doi | 11 |
molecular similarity | 11 |
stock solutions | 11 |
dopamine receptor | 11 |
ccr antagonists | 11 |
selective anti | 11 |
transcriptase inhibitors | 11 |
methanol extracts | 11 |
control group | 11 |
bglu inhibitory | 11 |
pot synthesis | 11 |
performance liquid | 11 |
wild type | 11 |
molecular targets | 11 |
antiprotozoal activity | 11 |
new chemical | 11 |
effi cacy | 11 |
binding cavity | 11 |
target product | 11 |
functional food | 11 |
pharmacy compounding | 10 |
endoplasmic reticulum | 10 |
concentration required | 10 |
also identified | 10 |
various concentrations | 10 |
times higher | 10 |
terminal region | 10 |
also able | 10 |
low nanomolar | 10 |
lethal dose | 10 |
acid groups | 10 |
cancer institute | 10 |
molecular interactions | 10 |
bismuth drugs | 10 |
virus ns | 10 |
wound healing | 10 |
diethylene glycol | 10 |
nabh cn | 10 |
benzofuran derivatives | 10 |
chemical synthesis | 10 |
data taken | 10 |
antibiofilm activity | 10 |
predicted metabolic | 10 |
oh unit | 10 |
protein binding | 10 |
pedv replication | 10 |
taken together | 10 |
domain ii | 10 |
different parts | 10 |
coronavirus spike | 10 |
currently used | 10 |
highly potent | 10 |
studies demonstrated | 10 |
boiling point | 10 |
trypanothione reductase | 10 |
spore germination | 10 |
plaque number | 10 |
cell monolayers | 10 |
toro virus | 10 |
may result | 10 |
supplementary data | 10 |
binding domain | 10 |
compounds identified | 10 |
also demonstrated | 10 |
glucosidase inhibitors | 10 |
membrane permeability | 10 |
dipeptidyl peptidase | 10 |
reached phase | 10 |
cytotoxic mannich | 10 |
dna duplex | 10 |
bioactivity score | 10 |
comprehensive review | 10 |
polymerase inhibitors | 10 |
coronavirus main | 10 |
plant material | 10 |
prepared according | 10 |
aqueous media | 10 |
regression equations | 10 |
chlorokojic acid | 10 |
reaction using | 10 |
condensation reaction | 10 |
quinoline derivatives | 10 |
acid side | 10 |
coxsackie virus | 10 |
using different | 10 |
compound causing | 10 |
punta toro | 10 |
head group | 10 |
tumour cells | 10 |
national cancer | 10 |
colletotrichum sp | 10 |
avian flu | 10 |
least potent | 10 |
compound formed | 10 |
coumarin scaffolds | 10 |
main proteases | 10 |
indole alkaloid | 10 |
virus disease | 10 |
health benefits | 10 |
multidrug resistance | 10 |
platelet aggregation | 10 |
derivatives based | 10 |
zika virus | 10 |
new compound | 10 |
fda alerts | 10 |
fcov fipv | 10 |
acid synthesis | 10 |
synergistic effect | 10 |
dna damage | 10 |
treatment options | 10 |
argon atmosphere | 10 |
ca ix | 10 |
effective antiviral | 10 |
hydrophobic interaction | 10 |
ph values | 10 |
anticonvulsant properties | 10 |
parasite plasmodium | 10 |
tinctoria leaves | 10 |
selective inhibition | 10 |
structureeactivity relationship | 10 |
cysteine protease | 10 |
ic nm | 10 |
using two | 10 |
comparative study | 10 |
dried rosette | 10 |
higher concentrations | 10 |
octanol water | 10 |
receptor subtypes | 10 |
randomized clinical | 10 |
hypochlorite ions | 10 |
substrate specificity | 10 |
protein kinases | 10 |
pharmacophore modeling | 10 |
trifl uridine | 10 |
molecular mass | 10 |
cell apoptosis | 10 |
diseases caused | 10 |
inhibit viral | 10 |
recently reported | 10 |
clinical isolates | 10 |
higher selectivity | 10 |
already mentioned | 10 |
bacterial cell | 10 |
selected structures | 10 |
cervical cancer | 10 |
molecules may | 10 |
next step | 10 |
stem cells | 10 |
linoleic acid | 10 |
measured using | 10 |
cervix carcinoma | 10 |
based inhibitors | 10 |
modeling studies | 10 |
density functional | 10 |
crude product | 10 |
bglu inhibitor | 10 |
prepared using | 10 |
morphological changes | 10 |
two novel | 10 |
moiety synthesis | 10 |
hca xii | 10 |
side effect | 10 |
derived bglu | 10 |
signaling pathways | 10 |
aminopeptidase type | 10 |
fold reduction | 10 |
dna minor | 10 |
exhibited potent | 10 |
free energies | 10 |
red blood | 10 |
phenyl rings | 10 |
starting antibiotic | 10 |
withdrawing groups | 10 |
inducing apoptosis | 10 |
various substituents | 10 |
necrosis factor | 10 |
nuclear magnetic | 10 |
benzoic acid | 10 |
human serum | 10 |
genetic algorithm | 10 |
significantly inhibited | 10 |
electron density | 10 |
recent literature | 10 |
hiv integrase | 10 |
different cancer | 10 |
fold greater | 10 |
compound libraries | 10 |
spike glycoprotein | 10 |
antibiotic activity | 10 |
methoxy groups | 10 |
functional theory | 10 |
molecular mechanisms | 10 |
compound sweet | 10 |
protective effect | 10 |
primary screening | 10 |
test sets | 10 |
biological systems | 10 |
ir spectrum | 10 |
drug candidate | 10 |
health effects | 10 |
feature selection | 10 |
rosette leaf | 9 |
fresh leaves | 9 |
two series | 9 |
enhanced production | 9 |
salt bridge | 9 |
large numbers | 9 |
dynamics simulations | 9 |
volatile compounds | 9 |
virus polymerase | 9 |
molecule rofecoxib | 9 |
nucleoside analogs | 9 |
heterocyclic compounds | 9 |
endophytic streptomyces | 9 |
antimicrobial evaluation | 9 |
zoi mm | 9 |
chemokine receptors | 9 |
antiviral compound | 9 |
hcv polymerase | 9 |
via pechmann | 9 |
protein coupled | 9 |
based screening | 9 |
natural antibiotics | 9 |
table shows | 9 |
also displayed | 9 |
ii trials | 9 |
synthesized chromone | 9 |
infected cell | 9 |
resulting mixture | 9 |
charge transfer | 9 |
vivo efficacy | 9 |
mechanistic studies | 9 |
time points | 9 |
microwave assisted | 9 |
transgenic mouse | 9 |
compounds ael | 9 |
hydroxycinnamic acids | 9 |
sindbis virus | 9 |
flash column | 9 |
antiviral action | 9 |
cyclic carbonate | 9 |
coumarin hybrids | 9 |
whereas compounds | 9 |
promising activity | 9 |
alkyl derivatives | 9 |
cell surface | 9 |
may provide | 9 |
chemical reactions | 9 |
compounds act | 9 |
anthracycline antibiotics | 9 |
low energy | 9 |
hit compounds | 9 |
compounds present | 9 |
previously shown | 9 |
lamarckian genetic | 9 |
may lead | 9 |
inhibitory action | 9 |
also potent | 9 |
molecular level | 9 |
dry ch | 9 |
administered orally | 9 |
natural sources | 9 |
lines using | 9 |
alternaria solani | 9 |
research group | 9 |
lung pathology | 9 |
sar analysis | 9 |
malaria parasite | 9 |
secondary products | 9 |
till date | 9 |
liver injury | 9 |
stacking interaction | 9 |
ccr antagonist | 9 |
receptor ligand | 9 |
approved drug | 9 |
mm compared | 9 |
ray crystal | 9 |
similarity searching | 9 |
antifungal properties | 9 |
one hand | 9 |
new approach | 9 |
structural modifications | 9 |
shown promising | 9 |
bait compounds | 9 |
membrane fusion | 9 |
inflammatory effect | 9 |
highly conserved | 9 |
feline herpes | 9 |
regression analysis | 9 |
west nile | 9 |
dipolar cycloaddition | 9 |
qsar study | 9 |
ala group | 9 |
induced cpe | 9 |
organic solvents | 9 |
structural proteins | 9 |
blood cells | 9 |
another important | 9 |
compound concentrations | 9 |
parasite growth | 9 |
analysis showed | 9 |
interesting biological | 9 |
coumarin moiety | 9 |
promising derivatives | 9 |
induced apoptosis | 9 |
methanolic extracts | 9 |
aminomethylated derivatives | 9 |
compounds inhibit | 9 |
aspartic acid | 9 |
simple coumarins | 9 |
carbon atom | 9 |
challenge virus | 9 |
particular interest | 9 |
steroidal alkaloids | 9 |
fungal infections | 9 |
pivot compound | 9 |
leukemia cell | 9 |
fl uorouridine | 9 |
coumarin based | 9 |
clinically useful | 9 |
human african | 9 |
significant influence | 9 |
clinical use | 9 |
nucleoside analogue | 9 |
higher plants | 9 |
compounding error | 9 |
collaborators investigated | 9 |
drug resistant | 9 |
cell walls | 9 |
disease resistance | 9 |
exhibited moderate | 9 |
gause institute | 9 |
red alga | 9 |
vitro study | 9 |
sephadex lh | 9 |
three times | 9 |
structural diversity | 9 |
active center | 9 |
qsar studies | 9 |
positively charged | 9 |
thiazole derivatives | 9 |
two gram | 9 |
potassium hydroxide | 9 |
series showed | 9 |
exhibited excellent | 9 |
values comparable | 9 |
medium supplemented | 9 |
human pathogenic | 9 |
antifungal potency | 9 |
pneumocystis carinii | 9 |
therapeutic options | 9 |
national institute | 9 |
studied bioactive | 9 |
molecular mechanism | 9 |
membrane potential | 9 |
isoforms i | 9 |
similar fashion | 9 |
afl oqualone | 9 |
competitive inhibition | 9 |
pyridine ring | 9 |
nile virus | 9 |
shoot cultures | 9 |
thyroid receptor | 9 |
human subjects | 9 |
alkyl groups | 9 |
molecular connectivity | 9 |
inhibitory potencies | 9 |
nucleophilic attack | 9 |
glucuronidase inhibition | 9 |
data analysis | 9 |
method described | 9 |
bases obtained | 9 |
cytotoxic towards | 9 |
methyl groups | 9 |
screening using | 9 |
colon carcinogenesis | 9 |
folic acid | 9 |
good selectivity | 9 |
toxicity profile | 9 |
products marine | 9 |
metabolic stability | 9 |
root rot | 9 |
fda approved | 9 |
jak inhibitors | 9 |
coumarins showed | 9 |
recent developments | 9 |
also studied | 9 |
cell membranes | 9 |
first reported | 9 |
state university | 9 |
oxidative phosphorylation | 9 |
moment along | 9 |
extracellular cgamp | 9 |
selective cox | 9 |
inhibit chloroquine | 9 |
new therapeutic | 9 |
pharmaceutical compounding | 9 |
promising sars | 9 |
food industry | 9 |
lead optimization | 9 |
another example | 9 |
reaction products | 9 |
neurodegenerative diseases | 9 |
prepared starting | 9 |
cyclic ketones | 9 |
selective activity | 9 |
fluoride ions | 9 |
highly specific | 9 |
hbv activity | 9 |
parkinson disease | 9 |
bond acceptor | 9 |
methionine aminopeptidases | 9 |
following day | 9 |
significant effect | 9 |
new semi | 9 |
specific antiviral | 9 |
uorouracil derivatives | 9 |
melting point | 9 |
nucleocapsid protein | 9 |
viral protein | 9 |
relatively large | 9 |
entry inhibitors | 9 |
good anti | 9 |
hepatoma cells | 9 |
embryonic lung | 9 |
alternative approach | 9 |
two types | 9 |
dichloromethane extracts | 9 |
biocontrol agents | 9 |
peptide core | 9 |
indole moiety | 9 |
similar binding | 9 |
novel coumarin | 9 |
recent study | 9 |
pharmacokinetic profile | 9 |
culture media | 9 |
ex vivo | 9 |
thymidine phosphorylase | 9 |
containing different | 9 |
infectious virus | 9 |
showed less | 9 |
workers focused | 9 |
water soluble | 9 |
reductase inhibitors | 9 |
plant diseases | 9 |
antiviral screening | 9 |
binding pockets | 9 |
vitro antifungal | 9 |
compound series | 9 |
human colon | 9 |
marine compounds | 9 |
drug target | 8 |
also included | 8 |
mmt assay | 8 |
canine kidney | 8 |
glycosidase inhibitors | 8 |
two orders | 8 |
primary amines | 8 |
aminofurazan yl | 8 |
whereas mannich | 8 |
final product | 8 |
liver cancer | 8 |
imidazole ring | 8 |
pseudomonas spp | 8 |
inhibitors compared | 8 |
novel antifungal | 8 |
fungal cells | 8 |
molecular devices | 8 |
derivatives linked | 8 |
identify novel | 8 |
molecular biology | 8 |
chemie gmbh | 8 |
survival rate | 8 |
bond lengths | 8 |
fungal species | 8 |
tba assay | 8 |
molecular electrostatic | 8 |
cross metathesis | 8 |
food sectors | 8 |
lower concentrations | 8 |
two mannich | 8 |
sulfated polysaccharides | 8 |
vitro antibacterial | 8 |
ring opening | 8 |
contamination errors | 8 |
key role | 8 |
fold stronger | 8 |
inhibited virus | 8 |
antiviral ec | 8 |
compounds showing | 8 |
resulting mannich | 8 |
three different | 8 |
showed similar | 8 |
showed inhibitory | 8 |
total synthesis | 8 |
organic phase | 8 |
rega institute | 8 |
medicinal properties | 8 |
relatively low | 8 |
data obtained | 8 |
african green | 8 |
dna topoisomerase | 8 |
several types | 8 |
novel therapeutic | 8 |
drug products | 8 |
phosphonic acid | 8 |
free reactions | 8 |
mic mg | 8 |
substituted piperazines | 8 |
strains compared | 8 |
antiproliferative effect | 8 |
bases showed | 8 |
urgent need | 8 |
double bonds | 8 |
betulin derivatives | 8 |
glycosidic linkage | 8 |
promyelocytic leukemia | 8 |
analyzed using | 8 |
built using | 8 |
viral polymerase | 8 |
respiratory disease | 8 |
fl uoropyrimidine | 8 |
cov main | 8 |
amino moiety | 8 |
similar structures | 8 |
drug molecules | 8 |
small series | 8 |
bioactive components | 8 |
lewis acid | 8 |
showed promising | 8 |
birch bark | 8 |
defense compound | 8 |
incubation period | 8 |
resistant viruses | 8 |
substituted phenols | 8 |
promising antiviral | 8 |
four different | 8 |
biological results | 8 |
graphpad prism | 8 |
hydroxyphenylacetic acid | 8 |
human respiratory | 8 |
indole mannich | 8 |
kojic acid | 8 |
toxic properties | 8 |
peritonitis virus | 8 |
stock solution | 8 |
viral titers | 8 |
group showed | 8 |
review article | 8 |
ppm assigned | 8 |
methanol extract | 8 |
biological effects | 8 |
hydroxamic acid | 8 |
lower cytotoxicity | 8 |
synergic effects | 8 |
brown alga | 8 |
sars cov | 8 |
administration fda | 8 |
domain i | 8 |
significantly increased | 8 |
human coronaviruses | 8 |
concentration errors | 8 |
inhibit human | 8 |
purine nucleoside | 8 |
nanomolar concentrations | 8 |
tumor necrosis | 8 |
selective inhibitory | 8 |
transgenic mice | 8 |
energy value | 8 |
inducing cell | 8 |
gas chromatography | 8 |
micromolar activity | 8 |
safety profile | 8 |
obtained compounds | 8 |
resistant parasites | 8 |
mycorrhizal fungi | 8 |
useful tool | 8 |
biological processes | 8 |
parainfluenza virus | 8 |
inhibition assays | 8 |
number reduction | 8 |
exhibited inhibition | 8 |
logp values | 8 |
reaction conditions | 8 |
derivatives via | 8 |
ml dmem | 8 |
cellular metabolism | 8 |
towards ache | 8 |
recent work | 8 |
point apparatus | 8 |
reaction time | 8 |
triazol yl | 8 |
antiproliferative activities | 8 |
thin layer | 8 |
i clinical | 8 |
presented prominent | 8 |
fold selectivity | 8 |
pe values | 8 |
atomic coordinates | 8 |
diseases including | 8 |
statistical significance | 8 |
guinea pig | 8 |
partial least | 8 |
double hydroxylation | 8 |
kinetic studies | 8 |
control mice | 8 |
chain length | 8 |
high level | 8 |
highly functionalized | 8 |
cervical carcinoma | 8 |
scientific community | 8 |
anticholinesterase activity | 8 |
rich source | 8 |
high mortality | 8 |
stib mouse | 8 |
solid tumors | 8 |
ch oc | 8 |
marine algae | 8 |
cell fusion | 8 |
results also | 8 |
boronic acid | 8 |
cxcr antagonists | 8 |
coupled receptors | 8 |
alkaline hydrolysis | 8 |
i value | 8 |
significant anti | 8 |
may cause | 8 |
develop new | 8 |
pyrazole derivatives | 8 |
compound resulted | 8 |
great potential | 8 |
falciparum strain | 8 |
quantitative analysis | 8 |
neuroprotective activity | 8 |
aerial parts | 8 |
resistance transporter | 8 |
adverse events | 8 |
dilution method | 8 |
potential target | 8 |
inactive compounds | 8 |
hit compound | 8 |
type diabetic | 8 |
comparative analysis | 8 |
compounds include | 8 |
oxidative damage | 8 |
enzyme inhibitory | 8 |
sprout extract | 8 |
literature data | 8 |
provided protection | 8 |
novel antiviral | 8 |
molecular orbital | 8 |
receptor site | 8 |
ray structure | 8 |
drug streptomycin | 8 |
hemorrhagic fever | 8 |
ligand binding | 8 |
novel chemical | 8 |
clpro inhibitors | 8 |
herpes viruses | 8 |
compound using | 8 |
normal human | 8 |
first stage | 8 |
cg ca | 8 |
fold lower | 8 |
different biological | 8 |
fungal diseases | 8 |
showed better | 8 |
increasing interest | 8 |
cc values | 8 |
molecular properties | 8 |
will also | 8 |
early stage | 8 |
ammonium salt | 8 |
rofecoxib structures | 8 |
dopamine receptors | 8 |
exhibited low | 8 |
tested concentration | 8 |
subsequently added | 8 |
relationship study | 8 |
supplementary table | 8 |
ncov main | 8 |
may act | 8 |
pb interaction | 8 |
compounds produced | 8 |
almost completely | 8 |
cancer agents | 8 |
white solid | 8 |
chemical similarity | 8 |
causative agent | 8 |
rat model | 8 |
antiviral evaluation | 8 |
negative control | 8 |
two classes | 8 |
high degree | 8 |
existing drugs | 8 |
several candidates | 8 |
vivo anti | 8 |
directed toward | 8 |
preclinical studies | 8 |
thymidylate synthase | 8 |
fruit antibacterial | 8 |
receptor agonists | 8 |
fret enzyme | 8 |
related gene | 8 |
electron transport | 8 |
also active | 8 |
fungal pathogenesis | 8 |
med chem | 8 |
biological targets | 8 |
tandem mass | 8 |
approach may | 8 |
claisen rearrangement | 8 |
aminomethyl derivatives | 8 |
amide group | 8 |
mic value | 8 |
tinctoria dried | 8 |
nucleoside reverse | 8 |
human use | 8 |
hiv aids | 8 |
clinically used | 8 |
phenol compounds | 8 |
increased potency | 8 |
trypanosomal agents | 8 |
also confirmed | 8 |
small linker | 8 |
chromone scaffold | 8 |
virus rna | 8 |
computational studies | 8 |
active agents | 8 |
activity may | 8 |
antitumor activities | 8 |
values greater | 8 |
autoimmune diseases | 8 |
protein structure | 8 |
biochemical experiments | 8 |
bovine liver | 8 |
connectivity index | 8 |
protein expression | 8 |
screening data | 8 |
influenza infection | 8 |
activity studies | 8 |
various types | 8 |
induced cytopathogenicity | 8 |
nucleoside phosphorylase | 8 |
simulations showed | 8 |
compound exhibits | 8 |
manilkara zapota | 8 |
thyroid hormone | 8 |
four common | 8 |
binding interactions | 8 |
nuclear receptor | 8 |
control cells | 8 |
chemical interactions | 8 |
dimethylglutaric anhydride | 8 |
common bacteria | 8 |
colon adenocarcinoma | 8 |
ifn alfacon | 8 |
antioxidant potential | 8 |
norovirus cl | 8 |
cell permeability | 8 |
tinctoria hairy | 8 |
positive bacterial | 8 |
different length | 8 |
vivo evaluation | 8 |
good inhibitory | 8 |
vitro screening | 8 |
similar compounds | 8 |
less effective | 8 |
generally less | 8 |
antiviral mechanism | 8 |
binding proteins | 8 |
lower activity | 8 |
excellent yields | 8 |
seed extract | 8 |
active form | 8 |
spectroscopic methods | 8 |
well plate | 8 |
chemotherapeutic agent | 8 |
trade name | 8 |
prompted us | 8 |
spectroscopic data | 8 |
dependent kinases | 8 |
many studies | 8 |
inhibition studies | 8 |
hcv replication | 8 |
acetylenic mannich | 8 |
kinase inhibitor | 8 |
tethered isatin | 8 |
catalytic acid | 8 |
antiviral agent | 8 |
generated using | 8 |
culture assays | 8 |
first two | 8 |
certain degree | 8 |
vancomycin aglycone | 8 |
hcv infection | 8 |
antimalarial drugs | 8 |
viral proteases | 8 |
nuclear factor | 8 |
cardiovascular disease | 8 |
biosafety level | 8 |
large quantities | 8 |
potent candidates | 8 |
cancer treatment | 8 |
steric effect | 8 |
ch cn | 8 |
inflammatory process | 8 |
also produced | 8 |
virus titer | 8 |
guided isolation | 8 |
fibril formation | 8 |
possible mechanisms | 7 |
also detected | 7 |
plate reader | 7 |
compounds lmqc | 7 |
infected patients | 7 |
amide function | 7 |
hcv rdrp | 7 |
caspase cascade | 7 |
structural insight | 7 |
biomedical coatings | 7 |
atomic charges | 7 |
virus activities | 7 |
linear relationship | 7 |
potent antifungal | 7 |
also described | 7 |
times lower | 7 |
active components | 7 |
collaborators synthesized | 7 |
japanese horse | 7 |
pdb code | 7 |
ligand complexes | 7 |
virus types | 7 |
crop protection | 7 |
financial support | 7 |
ray structures | 7 |
case study | 7 |
compound inhibits | 7 |
coumarin synthesis | 7 |
highly toxic | 7 |
dose response | 7 |
two phenolic | 7 |
exhibited antiviral | 7 |
viral titre | 7 |
flavonoid seeds | 7 |
gold standard | 7 |
bruker avance | 7 |
different stages | 7 |
th century | 7 |
lg ml | 7 |
polar solvation | 7 |
clinical efficacy | 7 |
bases generated | 7 |
serum albumin | 7 |
soft coral | 7 |
phosphate group | 7 |
new bioactive | 7 |
mg per | 7 |
base moiety | 7 |
moderate anti | 7 |
indian medicinal | 7 |
state analogue | 7 |
dry weight | 7 |
colorectal cancer | 7 |
free synthesis | 7 |
chronic inflammation | 7 |
organic acids | 7 |
brown macroalgae | 7 |
compound possesses | 7 |
colletotrichum gloeosporioides | 7 |
may occur | 7 |
hiv entry | 7 |
therapeutic targets | 7 |
target cells | 7 |
coumarins mentioned | 7 |
ii inhibitors | 7 |
lung carcinoma | 7 |
alkyl side | 7 |
cells via | 7 |
protein complexes | 7 |
calculated based | 7 |
bond formation | 7 |
selective toxicity | 7 |
fungi isolated | 7 |
displayed even | 7 |
inhibit sars | 7 |
synuclein oligomers | 7 |
epidermal growth | 7 |
phenolic profile | 7 |
cells per | 7 |
energy conformation | 7 |
complexes useful | 7 |
data collection | 7 |
plant parts | 7 |
feline corona | 7 |
clinical utility | 7 |
candidates showed | 7 |
significant improvement | 7 |
important biological | 7 |
induced cell | 7 |
including hela | 7 |
bioactive natural | 7 |
exhibited selective | 7 |
different strains | 7 |
aldrich gmbh | 7 |
plant foods | 7 |
compound ig | 7 |
viable cells | 7 |
ytterbium triflate | 7 |
vitro anticancer | 7 |
aliphatic chain | 7 |
cytopathic effects | 7 |
current status | 7 |
nh oh | 7 |
excellent antibacterial | 7 |
alkyne compound | 7 |
radical absorbance | 7 |
activity respect | 7 |
several drugs | 7 |
best profile | 7 |
amide bond | 7 |
hq derivatives | 7 |
acetyl group | 7 |
based derivatives | 7 |
vitro activities | 7 |
enzymatic activity | 7 |
synthetic pathway | 7 |
halogen substitution | 7 |
drug concentration | 7 |
ca xii | 7 |
utah state | 7 |
chemical reactivity | 7 |
blot analysis | 7 |
dual ccr | 7 |
yielded compound | 7 |
urgently needed | 7 |
green algae | 7 |
vehicle control | 7 |
sulfuric acid | 7 |
agar dilution | 7 |
replacement therapy | 7 |
spectrum inhibitors | 7 |
assay system | 7 |
several recent | 7 |
target derivative | 7 |
lysosomal enzymes | 7 |
sulfonamide group | 7 |
azole antifungals | 7 |
rmsd values | 7 |
pechmann reaction | 7 |
therapeutic index | 7 |
microglial cells | 7 |
life technologies | 7 |
untreated wells | 7 |
antioxidant agents | 7 |
novel approach | 7 |
binding ability | 7 |
drugs targeting | 7 |
compounds show | 7 |
fluorescent sensor | 7 |
highest anti | 7 |
time scales | 7 |
also presented | 7 |
hydrochloric acid | 7 |
agar diffusion | 7 |
significant differences | 7 |
polyene macrolides | 7 |
also noteworthy | 7 |
trypan blue | 7 |
pharmacological studies | 7 |
boc group | 7 |
directed ligands | 7 |
terminal amino | 7 |
inhibit virus | 7 |
also performed | 7 |
fresh weight | 7 |
steric hindrance | 7 |
afforded mannich | 7 |
significant difference | 7 |
prothrombin time | 7 |
displayed higher | 7 |
molecular structures | 7 |
plant products | 7 |
groups may | 7 |
compound emerged | 7 |
behloul wu | 7 |
metal chelating | 7 |
values higher | 7 |
several coumarin | 7 |
pyrimidine ring | 7 |
compound dilutions | 7 |
bacterial infections | 7 |
computational methods | 7 |
displayed stronger | 7 |
similar structure | 7 |
competing interests | 7 |
table reports | 7 |
isolated compound | 7 |
authors also | 7 |
compounds derived | 7 |
active towards | 7 |
attention due | 7 |
herpes virus | 7 |
well microtiter | 7 |
peripheral blood | 7 |
insulin resistance | 7 |
crystallographic analysis | 7 |
cell imaging | 7 |
human urine | 7 |
dynamics simulation | 7 |
tfa salts | 7 |
caulerpin molecule | 7 |
hydroxylated derivatives | 7 |
slightly weaker | 7 |
bases i | 7 |
irreversible human | 7 |
substituted isatins | 7 |
tree species | 7 |
glycol tethered | 7 |
different viruses | 7 |
inhibition activities | 7 |
two mutations | 7 |
order predicted | 7 |
tris buffer | 7 |
modified compounds | 7 |
nucleic acids | 7 |
fibroblast cells | 7 |
anticancer agent | 7 |
synthetic procedure | 7 |
compounds found | 7 |
blood glucose | 7 |
protonated piperazine | 7 |
hydroxamic acids | 7 |
per year | 7 |
potential inhibitor | 7 |
corylifolia seeds | 7 |
two decades | 7 |
cycle distribution | 7 |
human ether | 7 |
chromone molecule | 7 |
analysis revealed | 7 |
embryonic kidney | 7 |
antifungal drugs | 7 |
based pharmacophore | 7 |
nonstructural proteins | 7 |
blood levels | 7 |
vitro cytotoxicity | 7 |
future research | 7 |
previously demonstrated | 7 |
reference inhibitor | 7 |
compounds demonstrated | 7 |
contour map | 7 |
disease synthesis | 7 |
raw materials | 7 |
arterial blood | 7 |
structure determination | 7 |
antimicrobial properties | 7 |
extracellular viral | 7 |
examined using | 7 |
horse chestnut | 7 |
protease inhibition | 7 |
therapeutic approach | 7 |
allylic alcohol | 7 |
amide nh | 7 |
two molecules | 7 |
also inhibited | 7 |
xanthine oxidase | 7 |
gastrointestinal tract | 7 |
state analogues | 7 |
glucosidase inhibitor | 7 |
ache buche | 7 |
waste products | 7 |
new method | 7 |
transition metal | 7 |
aryl ring | 7 |
known compounds | 7 |
resistant mcf | 7 |
pyrrole derivatives | 7 |
higher inhibitory | 7 |
final products | 7 |
new generation | 7 |
fusion inhibitors | 7 |
green monkey | 7 |
bulgarian academy | 7 |
pedv inhibitory | 7 |
water extracts | 7 |
gmbh chemie | 7 |
cryptococcus neoformans | 7 |
electron transfer | 7 |
terminally modified | 7 |
pharmacophore model | 7 |
effectively inhibit | 7 |
care professionals | 7 |
acacia catechu | 7 |
lowest concentration | 7 |
wistar rats | 7 |
patients affected | 7 |
diffraction method | 7 |
hydroxycinnamic acid | 7 |
general structure | 7 |
starting antibiotics | 7 |
physicochemical parameters | 7 |
oral therapy | 7 |
cellular targets | 7 |
detailed study | 7 |
methods described | 7 |
small intestine | 7 |
prism software | 7 |
protein biosynthesis | 7 |
remarkable antibacterial | 7 |
vitro inhibition | 7 |
experimental evidence | 7 |
aminopeptidase inhibitors | 7 |
pharmacological profile | 7 |
mast cells | 7 |
protein targets | 7 |
ceric ammonium | 7 |
also effective | 7 |
dry pyridine | 7 |
mercaptoacetic acid | 7 |
low molecular | 7 |
healthy subjects | 7 |
spectrum antibacterial | 7 |
defense mechanisms | 7 |
structureeactivity relationships | 7 |
brucei gambiense | 7 |
halistanol sulfates | 7 |
catalytic amount | 7 |
aryl groups | 7 |
acid composition | 7 |
docking pose | 7 |
therapeutic significance | 7 |
another group | 7 |
virus production | 7 |
distilled water | 7 |
fingers domain | 7 |
decreased activity | 7 |
critical role | 7 |
transcriptase inhibitor | 7 |
crystal violet | 7 |
made using | 7 |
antimicrobial substances | 7 |
brown solid | 7 |
taxol production | 7 |
competitive inhibitors | 7 |
corylifolia linn | 7 |
structural elucidation | 7 |
digestive vacuole | 7 |
antagonistic activity | 7 |
many cases | 7 |
bioactive metabolites | 7 |
large scale | 7 |
showed anti | 7 |
acid glu | 7 |
endothelial cell | 7 |
important source | 7 |
binding protein | 7 |
also isolated | 7 |
technological applications | 7 |
online version | 7 |
ten years | 7 |
molecular formula | 7 |
prolonged release | 7 |
proliferative activities | 7 |
alerts health | 7 |
cell lung | 7 |
scientific literature | 7 |
crevicular fluid | 7 |
probably due | 7 |
ferulago cassia | 7 |
catalytic activity | 7 |
well diffusion | 7 |
coupling reaction | 7 |
induced inflammation | 7 |
bioisosteric replacement | 7 |
ann arbor | 7 |
compounds including | 7 |
secondary structure | 7 |
antiviral strategies | 7 |
cellular toxicity | 7 |
sulfonate derivatives | 7 |
colorless oil | 7 |
phenyl group | 7 |
plant cell | 7 |
corresponding piperidinols | 7 |
compound acts | 7 |
significative antibiofilm | 7 |
synthesized derivatives | 7 |
nonsteroidal anti | 7 |
genetic engineering | 7 |
binding assay | 7 |
real time | 7 |
antimicrobial screening | 7 |
safety profiles | 7 |
strong binding | 7 |
food samples | 7 |
based approaches | 7 |
type virus | 7 |
active compared | 7 |
four new | 7 |
type reaction | 7 |
compounds also | 7 |
research foundation | 7 |
single molecule | 7 |
liver bglu | 7 |
protonated nitrogen | 7 |
cancer types | 7 |
therapeutic intervention | 7 |
show activity | 7 |
effective concentrations | 7 |
anticonvulsant activities | 7 |
inhibitor activity | 7 |
compounds exhibit | 7 |
protein interaction | 7 |
intravenous administration | 7 |
uorine atom | 7 |
substituted analogues | 7 |
influenza activity | 7 |
cb receptor | 7 |
may produce | 7 |
carbonyl function | 7 |
santa cruz | 7 |
colon carcinoma | 7 |
point mutations | 7 |
viral genome | 7 |
flow cytometry | 7 |
new endophytic | 7 |
second generation | 7 |
malaria parasites | 7 |
metabolic activation | 7 |
liver metabolism | 7 |
showed characteristic | 7 |
donating groups | 7 |
th position | 7 |
inside lu | 7 |
sequence similarity | 7 |
allowed us | 7 |
vivo imaging | 7 |
administered i | 7 |
diazonium salt | 7 |
bioactive compound | 7 |
murine model | 7 |
medicinal applications | 7 |
strongest inhibitor | 7 |
human diseases | 7 |
cleavage sites | 7 |
human hepatoma | 7 |
exhibited inhibitory | 7 |
darby canine | 7 |
biological studies | 7 |
heterocyclic rings | 7 |
virus adsorption | 7 |
starting materials | 7 |
showed significative | 7 |
maximal inhibitory | 7 |
chromone ring | 7 |
untreated controls | 7 |
microdilution method | 7 |
different factors | 7 |
concentration tested | 7 |